Practice-Based Strategies: HER2-Positive Breast Cancer Case

Follow Practice-Based Strategies: HER2-Positive Breast Cancer Case
Share on
Copy link to clipboard

This case-based online mentor workshop podcast focuses on practical strategies to manage metastatic breast cancer in your patients with HER2-positive disease. Presented by Reshma Mahtani, DO, it includes prerecorded Q & A from the proceedings of live audioconferences. This workshop podcast is a sequ…

Projects In Knowledge, Inc


    • Oct 28, 2011 LATEST EPISODE
    • infrequent NEW EPISODES
    • 3m AVG DURATION
    • 8 EPISODES


    More podcasts from Projects In Knowledge, Inc

    Search for episodes from Practice-Based Strategies: HER2-Positive Breast Cancer Case with a specific topic:

    Latest episodes from Practice-Based Strategies: HER2-Positive Breast Cancer Case

    Part 8. Case Conclusion/Q & A Part 2

    Play Episode Listen Later Oct 28, 2011 5:22


    Dr. Mahtani answers additional questions from the live audience including how protocols have evolved in recent years and the need for accurate HER2 testing.

    Part 7. Case Conclusion/Q & A Part 1

    Play Episode Listen Later Oct 28, 2011 4:40


    Dr. Mahtani provides take-away messages from her case presentation on HER2-positive breast cancer, and then answers questions from the live audience. Topics include the use of trastuzumab and novel therapies in development for HER2-positive metastatic breast cancer.

    Part 6. Trastuzumab Beyond Progression

    Play Episode Listen Later Oct 28, 2011 1:19


    Dr. Mahtani discusses the use of trastuzumab in patients with HER2-positive metastatic breast cancer after progression on first-line trastuzumab.

    Part 5. Capecitabine/Lapatinib Combination Therapy and Toxicity

    Play Episode Listen Later Oct 28, 2011 2:03


    Dr. Mahtani discusses toxicity associated with combination regimens that include capecitabine and lapatinib.

    Part 4. Development of Brain Metastasis

    Play Episode Listen Later Oct 28, 2011 1:50


    Dr. Mahtani reviews the incidence of and factors associated with brain metastases in patients with HER2-positive metastatic breast cancer.

    Part 3. Novel Therapy T-DM1

    Play Episode Listen Later Oct 28, 2011 1:03


    Dr. Mahtani highlights the importance of novel therapies, such as TDM-1, in the treatment of HER2-positive metastatic breast cancer.

    Part 2. Trastuzumab for Small Node Negative HER2+ Tumors

    Play Episode Listen Later Oct 28, 2011 4:02


    Dr. Mahtani discusses the role of trastuzumab in selected patients with small HER2-positive tumors.

    Part 1. Case Presentation

    Play Episode Listen Later Oct 28, 2011 6:44


    Dr. Mahtani presents the case of a 44-year-old woman with a small HER2-positive tumor who progressed 2 years after initial mastectomy.

    Claim Practice-Based Strategies: HER2-Positive Breast Cancer Case

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel